The application relates to a compound of Formula (I′) or (I): ##STR00001##
or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of SSAO, a pharmaceutical composition comprising a compound of Formula (I′) or (I), and a method of treating or preventing a disease in which SSAO plays a role.

The present disclosure provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.

The present disclosure provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.

The present invention relates to substituted 4-methylene-tetrahydropyrans, 4-methyl-dihydropyrans and 4-methyl-tetrahydropyrans of formula (I), where the variables are as defined in the claims and description, to a stereoisomer thereof, to a mixture of stereoisomers thereof, to a mixture of different di- and tetrahydropyrans (I) and to a mixture containing at least one di- or tetrahydropyran (I) and at least one cyclic acetal which is a 1,3-dioxan carrying in 2-position an isobutanol-2-yl-(derived) substituent and in 4,4- or 5,5-position two methyl substituents. The invention also relates to the use of such compounds as an aroma chemical and/or for modifying and/or enhancing the aroma of a composition, to compositions comprising such compounds, to methods for preparing such compounds and to a product obtainable by these methods.

##STR00001##

The present invention relates to substituted 4-methylene-tetrahydropyrans, 4-methyl-dihydropyrans and 4-methyl-tetrahydropyrans of formula (I), where the variables are as defined in the claims and description, to a stereoisomer thereof, to a mixture of stereoisomers thereof, to a mixture of different di- and tetrahydropyrans (I) and to a mixture containing at least one di- or tetrahydropyran (I) and at least one cyclic acetal which is a 1,3-dioxan carrying in 2-position an isobutanol-2-yl-(derived) substituent and in 4,4- or 5,5-position two methyl substituents. The invention also relates to the use of such compounds as an aroma chemical and/or for modifying and/or enhancing the aroma of a composition, to compositions comprising such compounds, to methods for preparing such compounds and to a product obtainable by these methods.

##STR00001##

Provided is a polar compound having high chemical stability, high capability of aligning liquid crystal molecules, high solubility in a liquid crystal composition, and a large voltage holding ratio when used in a liquid crystal display device. The compound is represented by formula (1):

##STR00001##

in which, for example, R.sup.1 is alkyl having 1 to 15 carbons; MES is a mesogen group having at least one ring; Sp.sup.1 is a single bond or alkylene having 1 to 10 carbons; M.sup.1 and M.sup.2 are hydrogen; and R.sup.2 is a group represented by formulas (1a) to (1c):

##STR00002##

in which, Sp.sup.2 and Sp.sup.a are a single bond or alkylene having 1 to 10 carbons; S.sup.1 is >CH—; S.sup.2 is >C<; and X.sup.1 is —OH.

The present disclosure provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.

The invention relates to a liquid crystal compound having the structure of formula I wherein R is selected from the group consisting of H and alkyl or alkoxy groups of 1 to 12 carbon atoms in which one or more H are unsubstituted or substituted with halogen; A.sub.1 is selected from the group consisting of a single bond or a 1,4-phenylene group in which each H in the 1,4-phenylene group is independently substituted by one or more halogen atoms; L.sub.1 and L.sub.2 are each independently selected from H or halogen; Z.sub.1 is a single bond or —(CH.sub.2).sub.2—. The compound has advantages of low rotational viscosity, large dielectric anisotropy, good mutual solubility and stability, which can be added to LC composition to reduce the driving voltage of the display. Thus, the novel compound has prosperous applications in LCD industry.

##STR00001##

Disclosed is a novel stabilizer represented by formula I,

##STR00001##

Further disclosed is a liquid crystal composition comprising a compound of formula I. The liquid crystal composition disclosed in the present invention has a low viscosity γ.sub.1, a moderate dielectric anisotropy Δ∈, a moderate optical anisotropy Δn, and most principally a high reliability, and can achieve a quick response of liquid crystal display.

Disclosed is a novel stabilizer represented by formula I,

##STR00001##

Further disclosed is a liquid crystal composition comprising a compound of formula I. The liquid crystal composition disclosed in the present invention has a low viscosity γ.sub.1, a moderate dielectric anisotropy Δ∈, a moderate optical anisotropy Δn, and most principally a high reliability, and can achieve a quick response of liquid crystal display.